Evidence map›Paper›PMID 24700459›Full record

ReviewThe Journal of biological chemistry2014

Intein applications: from protein purification and labeling to metabolic control methods.

David W Wood, Julio A Camarero

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed.

  1. Article
  2. Synthetic Strategies for Activity-Based Probes to Decode Ubiquitin-Like Modifiers.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. A Unique THN Motif Is Critical for Enabling Efficient C-Terminal Traceless Cleavage.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. Frontiers in bioengineering and biotechnology · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Approaches to the Full and Partial Chemical Synthesis of Proteins.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. An artificially split class 3 intein.microPublication biology · 2023
    Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David W WoodFrom the Department of Chemical and Biomolecular Engineering, Ohio State University, Columbus, Ohio 43210 and wood.750@osu.edu.
Julio A Camarerothe Departments of Pharmacology and Pharmaceutical Sciences and Department of Chemistry, University of Southern California, Los Angeles, California 90033 jcamarer@usc.edu.

Funding

Cell-based screening and selection of cyclotide-based capture reagents for proteiR01GM090323 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CAMARERO, JULIO A · 2009 to 2013
$2.0M
NIGMS NIH HHS R01 GM090323NIGMS NIH HHS R01-GM090323
6 · The paper itself

Abstract

The discovery of inteins in the early 1990s opened the door to a wide variety of new technologies. Early engineered inteins from various sources allowed the development of self-cleaving affinity tags and new methods for joining protein segments through expressed protein ligation. Some applications were developed around native and engineered split inteins, which allow protein segments expressed separately to be spliced together in vitro. More recently, these early applications have been expanded and optimized through the discovery of highly efficient trans-splicing and trans-cleaving inteins. These new inteins have enabled a wide variety of applications in metabolic engineering, protein labeling, biomaterials construction, protein cyclization, and protein purification.

Indexed as

InteinsProtein EngineeringProteinsProtein SplicingRecombinant Fusion ProteinsStaining and LabelingTrans-SplicingProteinsRecombinant Fusion ProteinsInteinProtein Chemical ModificationProtein CyclizationProtein EngineeringProtein LabelingProtein ProcessingProtein PurificationProtein Self-assemblyProtein SplicingSelf-cleaving Tag

Identifiers

PMID24700459
PMCPMC4031509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.